News Conference News AHA 2022 Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION Michael O'Riordan November 09, 2022
News Conference News AHA 2022 Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study Michael O'Riordan November 07, 2022
News Conference News AHA 2022 Common ‘Heart’ Supplements Can’t Beat Statins: SPORT Michael O'Riordan November 06, 2022
News Conference News AHA 2022 ‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE Michael O'Riordan November 06, 2022
News Conference News AHA 2022 Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT Michael O'Riordan November 05, 2022
News Conference News AHA 2022 High-Sensitivity Troponin Testing on the Rise in the US but Still Limited Michael O'Riordan November 04, 2022
News Daily News Apixaban Again Linked to Less Bleeding in AF Patients Michael O'Riordan October 31, 2022
News Daily News More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials Michael O'Riordan October 28, 2022
News Daily News New Biomarker-Based Risk Score Performs Well in ACS Michael O'Riordan October 25, 2022
News Daily News Smartphone in Your Pocket Predicts 5-Year Risk of Dying Michael O'Riordan October 21, 2022
News Daily News Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest Michael O'Riordan October 20, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022
News Daily News FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs Michael O'Riordan October 17, 2022
News Conference News EACTS 2022 Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG Michael O'Riordan October 12, 2022
News Conference News EACTS 2022 FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry Michael O'Riordan October 07, 2022
News Daily News Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks Michael O'Riordan October 07, 2022
News Daily News COAPT Risk Score Useful in Predicting Outcomes in Functional MR Michael O'Riordan October 05, 2022
News Conference News HFSA 2022 GDMT With ARNI Linked to Less MR, May Obviate Need for Interventions Michael O'Riordan October 04, 2022
News Daily News Concerning or Reassuring? Long After COVID-19, CMR Still Yields Clues Michael O'Riordan October 03, 2022